Authors
Latest:
Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in EuropeSachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.
Latest:
Striving for Melanoma Advancements With the Melanoma Research AllianceMarc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
Latest:
Discussion of Traditional and Novel GPP Treatment ModalitiesAn expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.
Latest:
What You Need to Know About Mentoring DoctorsDefining the goals of the mentoring relationship can be useful to clarify expectations.
Latest:
Best Communication Practices to Explain Palliative Care PlansKatie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.
Latest:
Clascoterone cream 1% targets androgen receptorsThe topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.
Latest:
Tracee Blackburn, PA-C: Gut Health for Healthy SkinBlackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Latest:
From Clinic to Industry: Insights Into the MSL Role and PA AdvocacyAt the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.
Latest:
Rocco Serrao, MD Looks Ahead to Bimekizumab’s ApprovalWe had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.
Latest:
LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCCA coprimary end point in the phase 3 LEAP-010 study will not be met.
Latest:
Building Trust Through Cultural Competency in Aesthetic DermatologyExplore how cultural competency in aesthetic dermatology bridges trust gaps, ensuring inclusive care for patients of color and enhancing treatment outcomes.
Latest:
Tyk2 Inhibition Prevents Islet Inflammation and Delays Type 1 Diabetes Development in MiceNew research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
CAGE Bio Advances Skin Disease TreatmentMitragotri's work bridges advanced drug development and skin care for tailored treatments.
Latest:
Reviewing the Multifactorial Nature of Chronic Hand Eczema and Upcoming DelgocitinibAt the 2025 Revolutionizing Atopic Dermatitis Conference, JiaDe “Jeff” Yu, MD, MS, discussed the multifactorial nature of chronic hand eczema, highlighting its distinction from atopic dermatitis.
Latest:
OX40/OX40L Inhibitors Offer Upstream Signaling Pathways in Atopic DermatitisAt RAD 2025, Christopher Bunick, MD, PhD, presented data on amlitelimab and rocatinlimab, highlighting their potential to suppress cytokine signaling and more.
Latest:
Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic DermatologySteven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.
Latest:
RAPIDS 2025 Conference Recap: A Thrilling Journey Through Immuno-DermatologyRAPIDS 2025 captivated with expert insights on immuno-dermatology, featuring engaging sessions and lively panels.
Latest:
Looking at the scalp and nails during a skin exam is keyA presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Latest:
Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne VulgarisIn the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.
